Global diagnostic imaging equipment market is driven by factors such as growing technological advancement which include handheld X-ray & upright MRI and increasing interest among researcher regarding medical imaging equipment. Additionally, growing geriatric population with relatively weaker immune system, increasing government funding pertaining to diagnostic imaging studies are also responsible to drive the market. Furthermore, increasing patient awareness levels regarding early stage diagnosis and increasing demand for effective & efficient imaging technologies for diagnosis are few factors that are positively reinforcing the market over the forecast period. Moreover, growing population with unhealthy lifestyle, increasing incidences of chronic diseases such as cancer, cardiovascular disorder, gastrointestinal disorders and various genetic mutations that requires advanced imaging equipment are amongst few factors that are expected to positively reinforce the market growth. High cost associated with these devices and side effects of emitting radiations are few key factors that are expected to impede the diagnostic imaging devices market growth. However, advantages associated with these devices are expected to curb the effect of aforementioned factors.
Global diagnostic imaging equipment market is segmented on the basis of modality into ultrasound systems, magnetic resonance imaging (MRI) systems, X-ray imaging system, computed tomography (CT) systems, nuclear imaging systems, and mammography systems. In 2014, X-ray imaging system market was one of the highest revenue generating segments owing to increasing demand for cost effective diagnostic technique and rising patient awareness levels pertaining to the same. X-ray imaging system market is further segmented on the basis of technology (analog X-ray imaging systems and digital X-ray imaging systems) and portability (stationary X-ray imaging systems and portable X-ray imaging systems). In 2014, Digital X-ray imaging systems market was the major segment owing to increasing demand for enhanced imaging capabilities, and efficient procedural systems.
Ultrasound systems market is further segmented on the basis of technology, types of products and portability. Technologically, the ultrasound market is further segmented into diagnostic (2D, 3D & 4D ultrasound, and Doppler imaging) and therapeutic ultrasound (high-intensity focused ultrasound (HIFU) & extracorporeal shockwave lithotripsy (ESWL)). In 2014, therapeutic ultrasound segment was the largest segment of ultrasound systems markets owing to few factors such as new product development and increasing application areas of ultrasound systems. Based on types of products, the ultrasound market is segment into color ultrasound and black & white (B/W) ultrasound. However, on the basis of portability, the market is segment into cart/trolley based and handheld/compact ultrasound devices. Furthermore, computed tomography scanners market segment is further segmented on the basis of slice type into mid-end slice, low-end slice and high-end slice scanners. However, nuclear imaging systems market and mammography systems are segmented on the basis of product types and technologies respectively.
SPECT scanners & PET scanners are the types of products in nuclear imaging systems and analog & digital mammography systems are the technologies used in mammography. Moreover, MRI systems segment of diagnosis imaging equipment market is also segmented on the basis of architecture and field strength. Based on architecture, the MRI systems market is sub divided into closed and open MRI systems. In 2014, closed MRI was the highest revenue MRI system. On the basis of field strength, the market is sub divided into low-to-mid-field MRI, very-high-filed MRI, high-field MRI, and ultra-high-filed MRI. In 2014, the high-field MRI segment accounted for the largest share of the market owing to growing demand for exact images of soft tissues.
North America, Asia Pacific, Europe, MEA, and Latin America are the key region of diagnostic imaging equipment market. In 2014, North America was the largest regional market in terms of revenue owing to rising demand for advanced technologies such as 3D, 4D & mobile scanner and increasing need for early stage diagnose of various types of cancer & cardiovascular diseases. However, Asia Pacific region is expected to be the fastest growing regional market of global diagnostic imaging equipment over coming seven years. Growing demand for advances diagnostic techniques and rising awareness regarding the need of early stage diagnosis are few factors that are expected to drive the market in this region. Moreover, increasing geriatric population with lower immunity level and constantly improving reimbursement policies pertaining to the medical imaging market that in turn leads to increasing public & private hospital funding are some factors driving the market growth. Furthermore, Japan is anticipated to be the largest market in Asia Pacific owing to rising healthcare expenditure and increasing geriatric population with chronic conditions.
Key players of diagnostic imaging equipment market include GE Healthcare, Hitachi Medical Corporation, Hologic, Inc., Philips Healthcare, Samsung Medison, Siemens Healthcare Shimadzu Corporation, Toshiba Medical Systems Corporation, Carestream Health, Esaote S.p.A, and Hologic, Inc.
Avail customized purchase options to meet your exact research needs:
Get your queries resolved from an industry expert.
Design an exclusive study to serve your research needs.
A testimonial for service in the form of BBB "A" Accreditation.
Your personal and confidential information is safe and secure.
"The quality of research they have done for us has been excellent..."
Amongst the majorly used Covid-19 screening options, imaging is preferred by most healthcare professionals as it provides a primary diagnosis in a short time. All the imaging modalities including nuclear imaging have been used exhaustively to study Covid-19 and its effect on different patients in each demography. These are used in theories such as comparison of the vulnerability of pediatric and geriatric patients, and treatment response for several drug combinations. The rising requirement for advanced lung imaging solutions is expected to boost the development studies for lung phantoms. A detailed study on lung deterioration in Covid-19 patients is expected to provide advanced measures for early detection of the disease. The report will account for Covid19 as a key market contributor.